Trial Outcomes & Findings for Subjective Comfort With Multipurpose and Hydrogen Peroxide Lens Care Solutions in Soft Contact Lens Wearers (NCT NCT01164865)

NCT ID: NCT01164865

Last Updated: 2012-10-12

Results Overview

Ocular comfort was rated by the participant on a continuous visual analog scale from 0-100, where 0=extremely uncomfortable, 50=neither comfortable nor uncomfortable, and 100=extremely comfortable. The participant marked a horizontal line across the scale at the point that best described "how your eyes feel right now."

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

78 participants

Primary outcome timeframe

Baseline (Day 0), 2 weeks

Results posted on

2012-10-12

Participant Flow

Participants were recruited from two US study centers.

Participant milestones

Participant milestones
Measure
OPTI-FREE RepleniSH
OPTI-FREE RepleniSH multipurpose disinfecting solution used with study contact lenses on a daily basis for 2 weeks.
Clear Care
Clear Care contact lens care system used with study contact lenses on a daily basis for 2 weeks.
Overall Study
STARTED
39
39
Overall Study
COMPLETED
37
38
Overall Study
NOT COMPLETED
2
1

Reasons for withdrawal

Reasons for withdrawal
Measure
OPTI-FREE RepleniSH
OPTI-FREE RepleniSH multipurpose disinfecting solution used with study contact lenses on a daily basis for 2 weeks.
Clear Care
Clear Care contact lens care system used with study contact lenses on a daily basis for 2 weeks.
Overall Study
Lost to Follow-up
2
1

Baseline Characteristics

Subjective Comfort With Multipurpose and Hydrogen Peroxide Lens Care Solutions in Soft Contact Lens Wearers

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
OPTI-FREE RepleniSH
n=39 Participants
OPTI-FREE RepleniSH multipurpose disinfecting solution used with study contact lenses on a daily basis for 2 weeks.
Clear Care
n=39 Participants
Clear Care contact lens care system used with study contact lenses on a daily basis for 2 weeks.
Total
n=78 Participants
Total of all reporting groups
Age Continuous
37.1 years
STANDARD_DEVIATION 12.27 • n=5 Participants
41.5 years
STANDARD_DEVIATION 9.59 • n=7 Participants
39.3 years
STANDARD_DEVIATION 11.16 • n=5 Participants
Sex: Female, Male
Female
29 Participants
n=5 Participants
26 Participants
n=7 Participants
55 Participants
n=5 Participants
Sex: Female, Male
Male
10 Participants
n=5 Participants
13 Participants
n=7 Participants
23 Participants
n=5 Participants
Region of Enrollment
United States
39 participants
n=5 Participants
39 participants
n=7 Participants
78 participants
n=5 Participants

PRIMARY outcome

Timeframe: Baseline (Day 0), 2 weeks

Population: All participants who received regimen, satisfied the inclusion/exclusion criteria, and completed the 14-day treatment period, including completion of the Visit 2 evaluations.

Ocular comfort was rated by the participant on a continuous visual analog scale from 0-100, where 0=extremely uncomfortable, 50=neither comfortable nor uncomfortable, and 100=extremely comfortable. The participant marked a horizontal line across the scale at the point that best described "how your eyes feel right now."

Outcome measures

Outcome measures
Measure
OPTI-FREE RepleniSH
n=37 Participants
OPTI-FREE RepleniSH multipurpose disinfecting solution used with study contact lenses on a daily basis for 2 weeks.
Clear Care
n=38 Participants
Clear Care contact lens care system used with study contact lenses on a daily basis for 2 weeks.
Change From Baseline in Ocular Comfort Rating at 2 Weeks
-8.20 Units on a scale
Interval -13.84 to -2.55
-7.14 Units on a scale
Interval -12.74 to -1.54

PRIMARY outcome

Timeframe: 2 weeks

Population: All participants who received regimen, satisfied the inclusion/exclusion criteria, and completed the 14-day treatment period, including completion of the Visit 2 evaluations.

The Likert Questionnaire included 8 questions on selected comfort measures. All responses were recorded on a 5-point scale, where 1=Strongly Disagree, 2=Disagree, 3=Undecided, 4=Agree, and 5=Strongly Agree.

Outcome measures

Outcome measures
Measure
OPTI-FREE RepleniSH
n=37 Participants
OPTI-FREE RepleniSH multipurpose disinfecting solution used with study contact lenses on a daily basis for 2 weeks.
Clear Care
n=38 Participants
Clear Care contact lens care system used with study contact lenses on a daily basis for 2 weeks.
Likert Questionnaire Scores at 2 Weeks
I can comfortably wear my lenses
4.20 Units on a scale
Interval 3.96 to 4.44
4.24 Units on a scale
Interval 4.0 to 4.48
Likert Questionnaire Scores at 2 Weeks
My lenses stay moist from morning to evening
3.60 Units on a scale
Interval 3.28 to 3.92
3.69 Units on a scale
Interval 3.37 to 4.01
Likert Questionnaire Scores at 2 Weeks
The solution I use feels gentle on my eyes
4.00 Units on a scale
Interval 3.75 to 4.25
3.66 Units on a scale
Interval 3.41 to 3.91
Likert Questionnaire Scores at 2 Weeks
My lenses feel fresh
3.79 Units on a scale
Interval 3.52 to 4.05
4.03 Units on a scale
Interval 3.77 to 4.29
Likert Questionnaire Scores at 2 Weeks
At the end of the day, my vision is clear
3.54 Units on a scale
Interval 3.2 to 3.88
3.86 Units on a scale
Interval 3.52 to 4.19
Likert Questionnaire Scores at 2 Weeks
When I put my lenses in, they feel comfortable
4.05 Units on a scale
Interval 3.78 to 4.33
4.03 Units on a scale
Interval 3.76 to 4.3
Likert Questionnaire Scores at 2 Weeks
I like the way this product feels during handling
4.09 Units on a scale
Interval 3.84 to 4.34
3.66 Units on a scale
Interval 3.42 to 3.91
Likert Questionnaire Scores at 2 Weeks
My lenses feel moist
3.84 Units on a scale
Interval 3.56 to 4.12
3.64 Units on a scale
Interval 3.36 to 3.92

Adverse Events

OPTI-FREE RepleniSH

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Clear Care

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Jami Kern, Ph.D.

Alcon Global Medical Affairs

Phone: 1-888-451-3937

Results disclosure agreements

  • Principal investigator is a sponsor employee Alcon reserves the right of prior review of any publication or presentation of information related to the study.
  • Publication restrictions are in place

Restriction type: OTHER